Modulation of plasma cholesteryl ester transfer protein activity by unsaturated fatty acids in Tunisian type 2 diabetic women

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 16, Issue 1, 2006, Pages 44-53

  Smaoui, M ^a   Hammami, S ^b   Attia, N ^a   Chaaba, R ^a   Abid, N ^c   Kilani, N ^c   Kchaou, H ^c   Mahjoub, S ^b   Abid, M ^c   Hammami, M ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Cholesteryl ester transfer protein (CETP); Diet; Dietary fatty acids; Non insulin dependent diabetes mellitus (NIDDM); Type 2 diabetes mellitus

Indexed keywords

EID: 33645989455     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.05.011     Document Type: Article

References (48)

1. Hesler CB, Swensos T, Tall AR. Purification and characterization of human plasma cholesteryl ester transfer protein. J Biol Chem 1987;262:2275-82.
2. Yen FY, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest 1989;83:2018-24.
3. Bruce C, Tall AR. Cholesteryl ester transfer protein, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 1995;6:306-11.
4. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-74.
5. Inazu A, Koizumi J, Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 2000;11:389-96.
6. Tato F, Vega GL, Tall AR, Grundy SM. Relation between cholesterol ester transfer protein activity and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995;15:112-20.
7. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991;21:161-7.
8. Moulin P, Appel GB, Ginsberg HN, Tall AR. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipemia. J Lipid Res 1992;33:1817-22.
9. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613.
10. Betteridge DJ. Dyslipidaemia and diabetes. Pract Diab Int 2001;18(6):201-7.
11. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC. Accelerated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis 1993;104:69-77.
12. Elchebly M, Porokhov B, Pulcini T, Berthezene F, Ponsin G. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis 1996;123:93-101.
13. Dullaart RP, Riemens SC, Scheek LM, Van Tol A. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Invest 1999;29:663-71.
14. Fielding CJ, Reaven GM, Liu G, Fielding PE. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 1984;81:2512-6.
15. Stein Y, Dabach Y, Hollander G, Stein O. Cholesteryl ester transfer activity in hamster plasma: increase by fat and cholesterol rich diets. Biochim Biophys Acta 1990;1042:138-41.
16. Quinet EM, Agellon LB, Kroon PA, Mareel YL, Lee YC, Whitlock ME, et al. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest 1990;85:357-63.
17. Kushwaha RS, Reardon CA, Lewis DS, Qi Y, Rice KS, Getz GS, et al. Effect of dietary lipids on plasma activity and hepatic mRNA levels of cholesteryl ester transfer protein in high- and low-responding baboons (Papio species). Metabolism 1994;43:1006-12.
18. Lagrost L, Mensink RP, Dangremont VG, Temme EH, Desrumaux C, Athias A, et al. Variations in serum cholesteryl ester transfer and phospholipids transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis 1999;142:395-402.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-I and B in serum. Scand J Clin Lab Invest 1987;47:739-44.
21. Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, et al. Accelerated transfer of cholesteryl ester in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987;79:1217-25.
22. Inouye M, Tsutou A, Mio T, Sumino K. Detection of hydroxyl fatty acids from diabetic erythrocyte membranes. Horm Metab Res 1994;26:353-4.
23. Nutritionist IV Computer Analysis Program, version 3.1. N2 Computing, Hearst Corp., Salem, OR; 1994.
24. Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986;27:361.
25. Moulin P. La protéine de transfert du cholestérol estérifié (CETP). Sang Thrombose Vaisseaux 1995;7:475-85.
26. Guerin M, Le Goff W, Lassel TS, van Tol A, Steiner G, Chapman MJ. Proatherogenic role of elevated CET from HDL to VLDL1 and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol 2001;21:282-8.
27. Ritter MC, Bagdade JD. Contribution of glycaemic control, endogenous lipoproteins and cholesteryl ester transfer protein to accelerated cholesteryl ester transfer in IDDM. Eur J Clin Invest 1994;24:607-14.
28. Dullaart RPF, Groener JEM, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesteryl ester transfer activity in complicated Type I (insulin-dependent) diabetes mellitus: its relationship with serum lipids. Diabetologia 1989;32:14-9.
29. Ruotolo G, Parlavecchia M, Taskinen MR, Galimberti G, Zoppo A, Le NA, et al. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Diabetes Care 1994;17:6-12.
30. Arai T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S, et al. Increased cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994;14:1129-36.
31. Sutherland WH, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994;43:1362-6.
32. Radeau T, Robb M, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998;139(2):369-76.
33. Riemens SC, van Tol A, Sluiter WJ, Dullaart RP. Plasma phospholipids transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia 1998;41:929-34.
34. Kurushima H, Hayashi K, Shingu T, Kuga Y, Ohtani H, Okura Y, et al. Opposite effects on cholesterol metabolism and their mechanisms induced by dietary oleic acid and palmitic acid in hamsters. Biochim Biophys Acta 1995;1258:251-6.
35. Jansen S, Lopez-Miranda J, Castro P, Lopez-Segura F, Marin C, Ordovas JM, et al. Low-fat and high-mono-unsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men. Am J Clin Nutr 2000;72:36-41.
36. Monnier L, Slama G, Vialettes B, Ziegler O. ALFEDIAM Recommendations. Nutrition et diabète. Diabetes Metab 1995;21:207-17.
37. Glatz JFC, Soffers AEMF, Katan MB. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 1989;49:269-76.
38. Brown JE, Lindsay RM, Riemersma RA. Linoleic acid metabolism in the spontaneously diabetic rat: Δ6 desaturase activity vs. product/precursor ratios. Lipids 2000;35:1319-23.
39. Rodriguez Y, Christophe AB. Long chain ω6 polyunsaturated fatty acids in erythrocyte phospholipids are associated with insulin resistance in non-obese type 2 diabetics. Clin Chim Acta 2005;354:195-9.
40. Groener JEM, van Ramshorst EM, Katan MB, Mensink RP, van Tol A. Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects. Atherosclerosis 1991;87:221-6.
41. McPherson R, Lau P, Kussie P, Barett H, Tall AR. Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. Arterioscler Thromb Vasc Biol 1997;87:203-10.
42. Ma J, Folsom AR, Shahar E, Eckfeldt JH. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr 1995;62:564-71.
43. Barter PJ. Role of non-esterified fatty acids in regulating plasma cholesterol transport. Clin Exp Pharmacol Physiol 1991;18(2):77-9.
44. Lagrost L, Barter P. Effects of various non-esterified fatty acids on the particle size redistribution of high density lipoproteins induced by the human cholesteryl ester transfer protein. Biochim Biophys Acta 1991;1082:204-10.
45. Lagrost L, Florentin E, Guyard-Dangremont V, Athias A, Gandjini H, Lallemant C, et al. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vasc Biol 1995;15(9):1388-96.
46. Durlach V, Attia N, Zahouani A, Leutenegger M, Girard-Globa A. Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients. Atherosclerosis 1996;120(1-2):155-65.
47. Lebovitz HE, Banerji MA. Treatment of insulin resistance in diabetes mellitus. Eur J Pharmacol 2004;490:135-46.
48. Rodríguez Y, Christophe AB. Effect of diabetes mellitus and different treatments on plasma and erythrocyte phospholipid fatty acid composition in type 2 diabetics. Ann Nutr Metab 2004;48:335-42.